Cyproterone Acetate D7 - Request Quote
Cyproterone Acetate D7
| SZ CAT No: | SZ-C049D02 |
| CAS No | NA |
| Mol.F. | C24H22D7ClO4 |
| Mol.Wt. | 424.0 |
| Inv. Status | Synthesis on demand |
Chemical Name :
Shipping Temperature :
HSN Code :
Country of Origin :
Smiles :
Usage Note:
Cyproterone Acetate D7 is chemically (2aR,3aS,3bS,3cS,5aS,6R,8aS,8bR)-6-(Acetyl-d3)-10-chloro-3b,5a-dimethyl-2-oxo-2,2a,3,3a,3b,3c,4,5,5a,6,7,8,8a,8b-tetradecahydrocyclopenta[a]cyclopropa[g]phenanthren-6-yl-1-d acetate-d3. Cyproterone Acetate D7 is supplied with detailed characterization data compliant with regulatory guideline. Cyproterone Acetate D7 can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Cyproterone.
The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.
Applications & Regulatory Use Cases
buy high quality Cyproterone Acetate D7
Purchase Cyproterone Acetate D7
Cyproterone Acetate D7 suppliers
Cyproterone Acetate D7 manufacturers
Cyproterone Acetate D7 price
Order Cyproterone Acetate D7
Enquire Cyproterone Acetate D7
Cyproterone Acetate D7 cost
Cyproterone Acetate D7 Supplier
Cyproterone Acetate D7 Distributor
Cyproterone Acetate D7 for Method Validation
Cyproterone Reference Standard
Cyproterone Acetate D7 for ANDA Filing
Cyproterone Acetate D7 for Forced Degradation Studies
Cyproterone Acetate D7 Identification Standards
Cyproterone Acetate D7 for DMF Filing
Related Products
Disclaimer
SynZeal product information given on this website is as per the existing understanding while publishing the details on website. The customer is responsible for assessing the accuracy of the information at the time of actual purchase.
SynZeal will update these details as per new developments or findings in product specifications without further notice.


